Cocoa and wine polyphenols modulate platelet activation and function

被引:135
作者
Rein, D
Paglieroni, TG
Pearson, DA
Wun, T
Schmitz, HH
Gosselin, R
Keen, CL [1 ]
机构
[1] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA
[2] Med Fdn, Ctr Blood Res, Sacramento, CA USA
[3] Univ Calif Davis, Med Ctr, Dept Pathol, Sacramento, CA 95817 USA
[4] Univ Calif Davis, Med Ctr, Div Hematol & Oncol, Sacramento, CA 95817 USA
[5] Mars Inc, Hackettstown, NJ USA
关键词
polyphenols; red wine; cocoa beverage; platelet activation; GPIIb-IIIa complex; P-selectin; thrombosis; whole blood flow cytometry;
D O I
10.1093/jn/130.8.2120S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
There is speculation that dietary polyphenols can provide cardioprotective effects due to direct antioxidant or antithrombotic mechanisms. We report in vitro and postingestion ex vivo effects of cocoa procyanidins, a procyanidin-rich cocoa beverage and dealcoholized red wine (DRW) on human platelet activation. In a series of in vitro studies, cocoa procyanidin trimers, pentamers or DRW (3 and 10 mu mol/L) were incubated with citrated peripheral whole blood in the presence and absence of platelet agonists. Platelet activation was detected using fluorescent-labeled monoclonal antibodies recognizing the fibrinogen binding conformation of GPIIb-IIIa (referred to herein as PAC-1 binding) and the activation-dependent platelet epitope CD62P (P-selectin). The percentage of CD42a-positive platelets coexpressing PAC-1 binding and/or CD62P was determined by multiparameter flow cytometry. Procyanidin trimers, pentamers and DRW added to whole blood in vitro increased PAC-1 binding and P-selectin expression. In contrast, procyanidin trimers, pentamers and DRW inhibited the platelet activation in response to epinephrine. The effects on platelet activation of cocoa beverage and DRW consumption were also studied in healthy subjects. Citrated blood was obtained before and 2 and 6 h after the ingestion of a cocoa beverage, a caffeine-containing beverage, DRW or water. Platelet activation was measured by flow cytometry. The consumption of DRW did not affect the expression of activation-dependent platelet antigens, either unstimulated or after ex vivo activation with epinephrine. However, the consumption of DRW increased PAC-I binding in response to 100 mu mol/L ADP ex vivo. Cocoa consumption reduced platelet response to agonists ex vivo. The ingestion of water had no effect on platelet activation, whereas a caffeine-containing beverage augmented the response of platelets to epinephrine. In summary, select cocoa procyanidins and DRW added to whole blood in vitro increased expression of platelet activation markers in unstimulated platelets but suppressed the platelet activation response to epinephrine. In contrast, cocoa consumption suppressed unstimulated and stimulated platelet activation in whole blood. This suppressive effect observed on platelet reactivity may explain in part the reported cardioprotective effects of dietary polyphenols.
引用
收藏
页码:2120S / 2126S
页数:7
相关论文
共 61 条
[1]   HPLC method for the quantification of procyanidins in cocoa and chocolate samples and correlation to total antioxidant capacity [J].
Adamson, GE ;
Lazarus, SA ;
Mitchell, AE ;
Prior, RL ;
Cao, GH ;
Jacobs, PH ;
Kremers, BG ;
Hammerstone, JF ;
Rucker, RB ;
Ritter, KA ;
Schmitz, HH .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1999, 47 (10) :4184-4188
[2]  
ARDLIE NG, 1967, THROMB DIATH HAEMOST, V18, P670
[3]   Protection against peroxynitrite by cocoa polyphenol oligomers [J].
Arteel, GE ;
Sies, H .
FEBS LETTERS, 1999, 462 (1-2) :167-170
[4]   Chocolate as a source of tea flavonoids [J].
Arts, ICW ;
Hollman, PCH ;
Kromhout, D .
LANCET, 1999, 354 (9177) :488-488
[5]   Red wine consumption inhibits LDL oxidation and aggregation in humans and in atherosclerotic mice [J].
Aviram, M ;
Hayek, T ;
Fuhrman, B .
BIOFACTORS, 1997, 6 (04) :415-+
[6]  
BAK AAA, 1990, NETH J MED, V37, P242
[7]   Hemodynamic and electrophysiologic effects of acute chocolate ingestion in young adults [J].
Baron, AM ;
Donnerstein, RL ;
Samson, RA ;
Baron, JA ;
Padnick, JN ;
Goldberg, SJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (03) :370-+
[8]  
BIAGGIONI I, 1991, J PHARMACOL EXP THER, V258, P588
[9]  
Caccetta RAA, 2000, AM J CLIN NUTR, V71, P67
[10]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961